ATE257380T1 - Piperidine substanz-p-antagonist enthaltende emulsionsvorkonzentrate - Google Patents
Piperidine substanz-p-antagonist enthaltende emulsionsvorkonzentrateInfo
- Publication number
- ATE257380T1 ATE257380T1 AT99927760T AT99927760T ATE257380T1 AT E257380 T1 ATE257380 T1 AT E257380T1 AT 99927760 T AT99927760 T AT 99927760T AT 99927760 T AT99927760 T AT 99927760T AT E257380 T1 ATE257380 T1 AT E257380T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonist
- containing piperidine
- emulsion preconcentrates
- piperidine substance
- preconcentrates containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9811200.6A GB9811200D0 (en) | 1998-05-26 | 1998-05-26 | Organic compounds |
GBGB9818105.0A GB9818105D0 (en) | 1998-08-19 | 1998-08-19 | Organic compounds |
PCT/EP1999/003623 WO1999061025A1 (en) | 1998-05-26 | 1999-05-26 | Microemulsion preconcentrates containing a piperidine substance p antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE257380T1 true ATE257380T1 (de) | 2004-01-15 |
Family
ID=26313736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99927760T ATE257380T1 (de) | 1998-05-26 | 1999-05-26 | Piperidine substanz-p-antagonist enthaltende emulsionsvorkonzentrate |
Country Status (31)
Country | Link |
---|---|
US (2) | US20020156099A1 (de) |
EP (1) | EP1082119B1 (de) |
JP (1) | JP4083985B2 (de) |
KR (1) | KR20010043669A (de) |
CN (1) | CN1270714C (de) |
AR (1) | AR018376A1 (de) |
AT (1) | ATE257380T1 (de) |
AU (1) | AU755134B2 (de) |
BE (1) | BE1012143A5 (de) |
BR (1) | BR9910696A (de) |
CA (1) | CA2333154C (de) |
DE (2) | DE69914077T2 (de) |
DK (1) | DK1082119T3 (de) |
ES (1) | ES2214859T3 (de) |
FR (1) | FR2779145B1 (de) |
GB (1) | GB2353473A (de) |
HK (1) | HK1035137A1 (de) |
HU (1) | HUP0102202A3 (de) |
ID (1) | ID27096A (de) |
IL (1) | IL139501A0 (de) |
IT (1) | IT1313551B1 (de) |
NO (1) | NO20005920L (de) |
NZ (1) | NZ508325A (de) |
PE (1) | PE20000537A1 (de) |
PL (1) | PL344245A1 (de) |
PT (1) | PT1082119E (de) |
RU (1) | RU2240121C2 (de) |
SK (1) | SK17752000A3 (de) |
TR (1) | TR200003502T2 (de) |
TW (1) | TW537894B (de) |
WO (1) | WO1999061025A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW537894B (en) | 1998-05-26 | 2003-06-21 | Novartis Ag | A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist |
AU2003225260A1 (en) * | 2002-04-22 | 2003-11-03 | University Of Florida | Microemulsions for selective molecular separation |
GB0220953D0 (en) * | 2002-09-10 | 2002-10-23 | Novartis Ag | Organic compounds |
US7842791B2 (en) | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
FR2934954B1 (fr) | 2008-08-14 | 2011-07-22 | Commissariat Energie Atomique | Emulsion fluorescente de vert d'indocyanine |
FR2935001B1 (fr) * | 2008-08-14 | 2011-12-30 | Commissariat Energie Atomique | Emulsion fluorescente |
FR2934953B1 (fr) | 2008-08-14 | 2011-01-21 | Commissariat Energie Atomique | Nanoemulsions de nanocristaux |
FR2934955B1 (fr) | 2008-08-14 | 2011-07-08 | Commissariat Energie Atomique | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions |
US20150374835A1 (en) * | 2012-12-31 | 2015-12-31 | Jrx Biotechnology, Inc. | Liquid topical pharmaceutical nano-emulsion formulations |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3305689A1 (de) | 1983-02-18 | 1984-08-23 | Mack Chem Pharm | Pharmazeutische zubereitung mit retardwirkung |
US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
DE4220616C2 (de) | 1992-06-24 | 1994-12-22 | Byk Gulden Lomberg Chem Fab | Dexniguldipin zur intravenösen Verabreichung |
PT589843E (pt) | 1992-09-25 | 2002-04-29 | Novartis Ag | Composicoes farmaceuticas contendo ciclosporinas |
GB2278780B (en) * | 1993-05-27 | 1998-10-14 | Sandoz Ltd | Macrolide formulations |
DE69535127T2 (de) * | 1994-03-18 | 2007-02-15 | Supernus Pharmaceuticals, Inc. | Emulgierte arzneistoffabgabesysteme |
TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
GB2308545B (en) | 1994-10-26 | 1999-06-02 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
FR2728165A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
FR2728169A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
KR19980703354A (ko) * | 1995-03-27 | 1998-10-15 | 나카토미히로타카 | 피페리딘 유도체 |
NZ280689A (en) | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
AU2898297A (en) | 1996-05-24 | 1998-01-05 | Novartis Ag | Use of substance p antagonists for treating social phobia |
TW537894B (en) | 1998-05-26 | 2003-06-21 | Novartis Ag | A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist |
-
1999
- 1999-05-24 TW TW088108449A patent/TW537894B/zh not_active IP Right Cessation
- 1999-05-24 AR ARP990102454A patent/AR018376A1/es not_active Application Discontinuation
- 1999-05-25 BE BE9900364A patent/BE1012143A5/fr not_active IP Right Cessation
- 1999-05-25 PE PE1999000436A patent/PE20000537A1/es not_active Application Discontinuation
- 1999-05-26 PL PL99344245A patent/PL344245A1/xx unknown
- 1999-05-26 IT IT1999MI001164A patent/IT1313551B1/it active
- 1999-05-26 IL IL13950199A patent/IL139501A0/xx unknown
- 1999-05-26 PT PT99927760T patent/PT1082119E/pt unknown
- 1999-05-26 TR TR2000/03502T patent/TR200003502T2/xx unknown
- 1999-05-26 AU AU45008/99A patent/AU755134B2/en not_active Ceased
- 1999-05-26 CN CNB998066036A patent/CN1270714C/zh not_active Expired - Fee Related
- 1999-05-26 HU HU0102202A patent/HUP0102202A3/hu unknown
- 1999-05-26 SK SK1775-2000A patent/SK17752000A3/sk unknown
- 1999-05-26 ID IDW20002316A patent/ID27096A/id unknown
- 1999-05-26 DK DK99927760T patent/DK1082119T3/da active
- 1999-05-26 NZ NZ508325A patent/NZ508325A/xx unknown
- 1999-05-26 DE DE69914077T patent/DE69914077T2/de not_active Expired - Lifetime
- 1999-05-26 KR KR1020007012871A patent/KR20010043669A/ko not_active Application Discontinuation
- 1999-05-26 JP JP2000550485A patent/JP4083985B2/ja not_active Expired - Fee Related
- 1999-05-26 AT AT99927760T patent/ATE257380T1/de not_active IP Right Cessation
- 1999-05-26 ES ES99927760T patent/ES2214859T3/es not_active Expired - Lifetime
- 1999-05-26 DE DE19983247T patent/DE19983247T1/de not_active Withdrawn
- 1999-05-26 GB GB0028506A patent/GB2353473A/en not_active Withdrawn
- 1999-05-26 EP EP99927760A patent/EP1082119B1/de not_active Expired - Lifetime
- 1999-05-26 BR BR9910696-5A patent/BR9910696A/pt not_active Application Discontinuation
- 1999-05-26 CA CA002333154A patent/CA2333154C/en not_active Expired - Fee Related
- 1999-05-26 FR FR9906629A patent/FR2779145B1/fr not_active Expired - Fee Related
- 1999-05-26 RU RU2000133308/15A patent/RU2240121C2/ru not_active IP Right Cessation
- 1999-05-26 WO PCT/EP1999/003623 patent/WO1999061025A1/en not_active Application Discontinuation
-
2000
- 2000-11-23 NO NO20005920A patent/NO20005920L/no not_active Application Discontinuation
-
2001
- 2001-08-16 HK HK01105781A patent/HK1035137A1/xx not_active IP Right Cessation
-
2002
- 2002-04-10 US US10/119,549 patent/US20020156099A1/en not_active Abandoned
-
2003
- 2003-03-04 US US10/379,345 patent/US6949257B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI971685A (fi) | Takykiniini-antagonisteja | |
EE9600186A (et) | Neurokiniini (tahhüülkiniini) antagonistid | |
NO951613D0 (no) | Ikke-peptidyl tachykinin reseptorantagonister | |
NO993575L (no) | Ny anordning | |
NO20032382D0 (no) | LFA-1-antagonistforbindelser | |
DE69920668D1 (de) | Cyclosporin oder macrolide enthaltende emulsionsvorkonzentrate | |
NO20015070D0 (no) | Paroksetin-hydroklorid-anhydrat | |
DE69826425D1 (de) | Organopolysiloxan-Emulsionen | |
DK1089996T3 (da) | Paroxetin-methansulfonat-acetonitril-solvat 1:1 | |
DE69841155D1 (de) | Emulsionzusammensetzung | |
DK1029027T3 (da) | Emulsionsblandinger | |
DE69626220D1 (de) | 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten | |
NO20000542L (no) | Endothelin-antagonister | |
ATE286022T1 (de) | Naphthalin-carboxamide als tachykinin rezeptorantagonisten | |
ATE257380T1 (de) | Piperidine substanz-p-antagonist enthaltende emulsionsvorkonzentrate | |
DE19882894T1 (de) | Draht-Funkenerosionseinrichtung | |
FR2758327B1 (fr) | Nouvelles arylpiperazines derivees de piperidine | |
DE69732715D1 (de) | Tachykinin antagoniste | |
DE59802319D1 (de) | Elektrolysevorrichtung | |
FI980488A0 (fi) | Ny diagnostisk metod | |
DE69821642D1 (de) | Substituierte oxime als neurokinin antagonisten | |
FI965116A0 (fi) | Uusia opioidipeptidiantagonisteja | |
DE19882876T1 (de) | Elektroerosions-Vorrichtung | |
NO20000541L (no) | Stratifikasjonsresistente emulsjoner | |
NO20005683D0 (no) | Ny formulering inneholdende paroxetin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1082119 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |